Spots Global Cancer Trial Database for chart abstraction
Every month we try and update this database with for chart abstraction cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Does the Use of a Genomic Tumor Board Increase the Number of Patients Who Receive Genome-Informed Treatment | NCT05455606 | Advanced Malign... Metastatic Mali... Recurrent Malig... Refractory Mali... | Best Practice Chart Abstracti... Educational Int... Genomic Profile Interview Questionnaire A... Tumor Board Rev... | 18 Years - | SWOG Cancer Research Network | |
HER2+ Breast Cancer Neo-Adjuvant Coordination of Care Program | NCT02616133 | Breast Cancer | chart abstracti... | - | Duke University | |
HER2+ Breast Cancer Neo-Adjuvant Coordination of Care Program | NCT02616133 | Breast Cancer | chart abstracti... | - | Duke University | |
NCCN Renal Cell Registry | NCT02677337 | Renal Cell Carc... | chart abstracti... Educational Pro... | 18 Years - | Duke University | |
Does the Use of a Genomic Tumor Board Increase the Number of Patients Who Receive Genome-Informed Treatment | NCT05455606 | Advanced Malign... Metastatic Mali... Recurrent Malig... Refractory Mali... | Best Practice Chart Abstracti... Educational Int... Genomic Profile Interview Questionnaire A... Tumor Board Rev... | 18 Years - | SWOG Cancer Research Network |